Pilocarpine HCl Ophthalmic Solution

DRUG4 trials

Sponsors

Allergan, CSPC Ouyi Pharmaceutical Co., Ltd., Southern College of Optometry

Conditions

Dry EyeGlassesPresbyopia

Phase 3

Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia

CompletedNCT03804268

AllerganPresbyopia

Start: 2018-12-21End: 2019-10-31Updated: 2021-12-28

A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia

CompletedNCT03857542

AllerganPresbyopia

Start: 2019-03-01End: 2020-09-10Updated: 2021-12-29

Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With Presbyopia

Not yet recruitingNCT06451666

CSPC Ouyi Pharmaceutical Co., Ltd.Presbyopia

Start: 2024-06-30End: 2025-12-30Target: 330Updated: 2024-07-03

Phase 4

Quality of Life in Presbyopic Patients Who Are Treated With Qlosi

RecruitingNCT07113210

Southern College of OptometryDry Eye, Glasses, Presbyopia

Start: 2025-07-18End: 2025-11-15Target: 36Updated: 2025-08-12

Related Papers

Safety and Efficacy of AGN-190584 in Individuals With Presbyopia

JAMA Ophthalmology2022-03-0345 citations

Development of the Presbyopia Impact and Coping Questionnaire.

2021-10-137 citations